Early gastric cancer and gastric dysplasia

Annali Italiani di Chirurgia

Volumn 67, Issue 3, 1996, Pages 391-397

  Pascal, R R ^a   Santeusanio, G ^b   Spagnoli, L G ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; GASTROSCOPY; GENETICS; HUMAN; MICROBIOLOGY; PATHOLOGY; REVIEW; STOMACH; STOMACH TUMOR;

ADENOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; GASTROSCOPY; HUMANS; STOMACH; STOMACH NEOPLASMS;

EID: 0030133074     PISSN: 2239253X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery. Jpn J Surg, 3:61-75, 1973.
2. Green P.H.R., O'Toole K.M., Weinberg L.M., Goldfarb J.P.: Early gastric cancer. Gastroenterol, 81:247-256, 1981.
3. Correa P., Tahara E.: Stomach. In: Henson D.E., Albores-Saavedra J., ed. Pathology of Incipient Neoplasia. Philadelphia, W.B. Saunders Company, 1993:85-103.
4. Antonioli D.A.: Gastric Carcinoma and Its Precursors. In: Goldman H., Appelman H.D., Kaufman N., ed. Gastrointestinal Pathology. Baltimore: Williams & Wilkins, 1990: 144-180. (Kaufman N., ed. United States and Canadian Academy of Pathology Monogaphs in Pathology).
5. Crespi M., Grassi A.: Overview of early gastric cancer and results of an Italian survey. Ital J Gastroenterol, 20:130-133, 1988.
6. Inokuchi K., Kodama Y., Sasaki O., Kamegawa T., Okamura T.: Differentiation of growth patterns of early gastric carcinoma determined by cytophotometric DNA analysis. Cancer, 51:1138-1141, 1983.
7. Kodama Y., Inokuchi K., Soejima K., et al.: Growth patterns and prognosis of early gastric carcinoma. Superficially spreading and penetrating growth patterns. Cancer, 51:320-326, 1983.
8. Hizawa K., Otsuka H., Inaba H., Izumi K., Nakanishi S.: Subcutaneous pseudosarcomatous polyvinylpyrrolidine granuloma. Am J Surg Pathol, 8:393-398, 1984.
9. Kuo T-T., Hsueh S.: Mucicarminophilic histiocytosis. A polyvinylpyrrolidine (PVP) storage disease simulating signet-ring cell carcinoma. Am J Surg Pathol, 8:419-428, 1984.
10. Antonioli D.A.: Precursors of gastric carcinoma: A critical review with a brief description of early (curable) gastric cancer. Hum Pathol, 25:994-1005, 1994.
11. Hui P.K., Chan W.Y., Cheung P.S., Chan J.K.C., Ng C.S.: Pathologic changes of gastric mucosa colonized by Helicobacter pylori. Hum Pathol, 23:548-556, 1992.
12. Eaton K.A., Krakowka S.: Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterol, 103:1580-1586, 1992.
13. Nogueira A.M.M., Ribeiro G.M., Rodrigues M.A.G., et al.: Prevalence of Helicobacter pylori in Brazilian patients with gastric carcinoma. Am J Clin Pathol, 100:236-239, 1993.
14. Parsonnet J., Vandersteen D., Goates J., et al.: Helicobacrerpylori infection in intestinal- and diffuse-type gastric adenocarcinoma. J Natl Cancer Inst, 83:640-643, 1991.
15. Recavarren-Arce S., Leon-Barua R., Cok J., et al.: Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand Gastroenterol, 26 (suppl 181):51-57, 1991.
16. Nomura A., Stemmermann G.N., Chyou P.H., et al.: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med, 325:1132-1136, 1991.
17. Correa P., Fox J., Fontham E., et al.: Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks. Cancer, 66:2569-2574, 1990.
18. Filipe M.I., Potet F., Bogomoletz W.V., et al.: Incomplete sulpho-mucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut, 26:1319-1326, 1985.
19. Filipe M.I., Barbatis C, Sandey A., Ma J.: Expression of intestinal mucin antigens in the gastric epithelium and its relationship with malignancy. Hum Pathol, 19:19-26, 1988.
20. Jass J.R., Filipe M.I.: The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants in gastric carcinoma. Histochem J, 13:931-939, 1981.
21. Jass J.R., Filipe M.I.: A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathol, 191-199, 1979.
22. Jass J.R.: Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol, 33:801-810, 1980.
23. Sipponen P.: Intestinal metaplasia and gastric carcinoma. Ann Clin Res, 13:139-143, 1981.
24. Munoz N., Crespi M., Correa P., et al.: Prevalence of precancerous lesions of the stomach and Helicobacter pylori in China. Ital J Gastroenterol, 23 (suppl 2):5-6, 1991.
25. Ghandur-Mnaymneh L., Paz J., Roldan E., Cassady J.: Dysplasia of nonmetaplastic gastric mucosa. A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma. Am J Surg Pathol, 12:96-114, 1988.
26. Jass J.R.: A classification of gastric dysplasia. Histopathol., 7:181-193, 1983.
27. Riddell R.H., Goldman H., Ranshoff D.F., et al.: Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical imolications. Hum Pathol, 14:931-968, 1983.
28. Saraga E.P., Gardiol D., Costa J.: Gastric dysplasia: a histological follow-up study. Am J Surg Pathol, 11:788-796, 1987.
29. Farini R., Pagnini CA, Farinati F., et al.: Is mild gastric epithelial dysplasia an indication for follow-up? J Clin Gastroenterol, 5:307-310, 1983.
30. Clark CG., Fesini A., Gledhill T.: Cancer following gastric surgery. Br J Surg, 72:591-594, 1985.
31. Lundegardh G., Adami H-O., Helmick C, Zack M., Meirik O.: Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med, 319:1094-1098, 1988.
32. Fenoglio CM., Kaye G.I., Lane N.: Distribution of human colonic lymphatics in normal, hyperplastic, and adenomatous tissue. Gastroenterol, 64:51-66, 1973.
33. Lehnen T., Erlandson R.A., Decosse J.J.: Lymph and blood capillaries of the human gastric mucosa. Gastroenterol, 939-950, 1985.
34. Listrom M.B., Fenoglio-Preiser C.M.: Lymphatic distribution of the stomach in normal, inflammatory, hyperplastic, and neoplastic tissue. Gastroenterol, 93:506-514, 1987.
35. Qizilbash A.H., Stevenson G.W.: Early gastric cancer. In: Sommers S.C., Rosen P.P., ed. Pathobgy Annual. New York: Appleton-Century-Crofts, 1979:317-351, vol 14, Part 1.
36. Oohara T., Tohma H., Takezoe K., et al.: Minute gastric cancers less than 5 mm in diameter. Cancer, 50:801-810, Cancer.
37. Falck V.G., Gullick W.J.: c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol, 159:107-111, 1989.
38. Yokota J., Yamamoto T., Toyoshima K., et al.: Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet, i:765-767, 1986.
39. Yokota J., Yamamoto T., Miyajima N., et al.: Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene, 4:283-287, 1988.
40. Fukayama M., Hayashi Y., Iwasaki Y., et al.: Epstein-Barr virus associated gastric carcinoma and Epstein-Bar virus infection of the stomach. Lab Invest, 71:73-81, 1994.
41. Shibata D., Weiss L.M.: Epstein-Barr virus associated gastric adenocarcinoma. Am J Pathol, 140:769-774, 1992.
42. Tokunaga M., Land CE., Uemura Y., Tokudome T., Tanaka S., Sato E.: Epstein-Barr virus in gastric carcinoma. Am J Pathol, 143:1250-1254, 1993.
43. Stemmerman G., Heffelfinger S.C, Noffsinger A., Hui Y.Z., Miller M.A., Fenoglio-Preiser CM.: The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol, 25:968-981, 1994.
44. Cho J.-H., Noguchi M., Ochiai A., Uchino S., Hirohashi S.: Analysis of regional differences of p53 mutation in advanced gastric carcinoma: relation to heterogeneous differentiation and invasiveness. Modern Pathol., 7:205-211, 1994.
45. Lauwers G.Y., Wahl S., Melamed J., Rojascorona R.R.: p53 Expression in Precancerous Gastric Lesions - An Immunohistochemical Study of Pab 1801 Monoclonal Antibody on Adenomatous and Hyperplastic Gastric Polyps. Am J Gastroenterol, 88:1916-1919, 1993.
46. Fukunaga M., Monden T., Nakanishi H., et al.: Immunohistochemical study of p53 in gastric carcinoma. Am J Clin Pathol, 101:177-180, 1994.
47. Shiao Y.H., Rugge M., Correa P., Lehmann H.P., Scheer W.D.: p53 alteration in gastric precancerous lesions. Am J Pathol, 144:511-517, 1994.
48. Rhyu M.G., Park W.S., Jung Y.J., Choi S.W., Meltzer S.J.: Allelic deletions of MMCIAPC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterol, 106:1584-1588, 1994.
49. Washington K., Gottfried M.R., Telen M.J.: Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol, 25:1043-1049, 1994.
50. Lee E.Y., Cibull M.L., Strodel W.E., Haley J.V.: Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. Arch Pathol Lab Med, 118:235-239, 1994.
51. Grigioni W.F., D'Errico A., Fortunato C., et al.: Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Modern Pathol, 7:220-225, 1994.